in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (3 days ago)
"Save the dates for OpenTox Euro 2017 Meeting" https://t.co/muWLfrAPZb on @LinkedIn
Douglas Connect (5 days ago)
RT @EU_ToxRisk: Global Summit on Regulatory Science ANVISA Brazil Sept.18-20, 2017 #Drug #FoodSafety #FDA #JRC @EFSA_EU @DouglasConn https:…
Douglas Connect (1 week ago)
Advancing reproducible regulatory science and practice #reproducibility #GSRS17 #RegulatoryScience… https://t.co/DmkFYO98kD
Douglas Connect (2 weeks ago)
RT @barryhardy: Working together on Safety Assessment - a Model for Collaboration @DouglasConn stand 41 #ToxHQ #EuroTox2017 https://t.co/Y0…
Douglas Connect (2 weeks ago)
RT @barryhardy: #Integrated #Testing #Strategy #Skin #Sensitization Application available for Evaluation #EuroTox2017 Douglas Connect stand…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com